Expression of an antisense transforming growth factor-β1 transgene reduces tumorigenicity of EMT6 mammary tumor cells

Julie A. Park, Ena Wang, Robert A. Kurt, Samuel F. Schluter, Evan M. Hersh, Emmanuel T. Akporiaye

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Transforming growth factor-β (TGF-β) is a potent immunosuppressive cytokine produced by many tumor cells. Secretion of TGF-β by malignant cells may therefore be a mechanism by which tumor cells escape destruction by tumor-specific T lymphocytes. In order to evaluate the role of tumor-derived TGF-β on tumor progression, we have inhibited the production of this cytokine by introducing a gene encoding antisense TGF-β1 into the EMT6 murine mammary tumor cell line using a retroviral vector (Las-TGF-β1SN). EMT6 cells transduced with this vector (EMT6as-TGF-β1 ) stably expressed the antisense gene and secreted 52% less TGF-β than did tumor cells transduced with the backbone vector alone. Supernatant fluid recovered from tumor cells expressing the antisense TGF-β1 gene also exhibited a decreased capacity to inhibit alloantigen-specific cytotoxic T-cell responses in vitro. Furthermore, tumor growth in mice injected with EMT6as-TGF-β1 tumor cells was inhibited compared to mice injected with control tumor cells. These results demonstrate that expression of antisense TGF-β1 by transduced EMT6 cells decreases their tumorigenicity and suggest that this approach of eliminating immune suppression is a potentially useful strategy to enhance antitumor responses.

Original languageEnglish
Pages (from-to)42-50
Number of pages9
JournalCancer Gene Therapy
Volume4
Issue number1
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Transforming Growth Factors
Transgenes
Breast Neoplasms
Neoplasms
Cytokines
Tumor Escape
Genes
T-Lymphocytes
Isoantigens
Immunosuppressive Agents
Tumor Cell Line

Keywords

  • Antisense TGF-β
  • Antitumor immunity
  • EMT6 mammary carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Park, J. A., Wang, E., Kurt, R. A., Schluter, S. F., Hersh, E. M., & Akporiaye, E. T. (1997). Expression of an antisense transforming growth factor-β1 transgene reduces tumorigenicity of EMT6 mammary tumor cells. Cancer Gene Therapy, 4(1), 42-50.

Expression of an antisense transforming growth factor-β1 transgene reduces tumorigenicity of EMT6 mammary tumor cells. / Park, Julie A.; Wang, Ena; Kurt, Robert A.; Schluter, Samuel F.; Hersh, Evan M.; Akporiaye, Emmanuel T.

In: Cancer Gene Therapy, Vol. 4, No. 1, 1997, p. 42-50.

Research output: Contribution to journalArticle

Park, Julie A. ; Wang, Ena ; Kurt, Robert A. ; Schluter, Samuel F. ; Hersh, Evan M. ; Akporiaye, Emmanuel T. / Expression of an antisense transforming growth factor-β1 transgene reduces tumorigenicity of EMT6 mammary tumor cells. In: Cancer Gene Therapy. 1997 ; Vol. 4, No. 1. pp. 42-50.
@article{9bf2f8c3db6f4e189ac8a735b4fefd88,
title = "Expression of an antisense transforming growth factor-β1 transgene reduces tumorigenicity of EMT6 mammary tumor cells",
abstract = "Transforming growth factor-β (TGF-β) is a potent immunosuppressive cytokine produced by many tumor cells. Secretion of TGF-β by malignant cells may therefore be a mechanism by which tumor cells escape destruction by tumor-specific T lymphocytes. In order to evaluate the role of tumor-derived TGF-β on tumor progression, we have inhibited the production of this cytokine by introducing a gene encoding antisense TGF-β1 into the EMT6 murine mammary tumor cell line using a retroviral vector (Las-TGF-β1SN). EMT6 cells transduced with this vector (EMT6as-TGF-β1 ) stably expressed the antisense gene and secreted 52{\%} less TGF-β than did tumor cells transduced with the backbone vector alone. Supernatant fluid recovered from tumor cells expressing the antisense TGF-β1 gene also exhibited a decreased capacity to inhibit alloantigen-specific cytotoxic T-cell responses in vitro. Furthermore, tumor growth in mice injected with EMT6as-TGF-β1 tumor cells was inhibited compared to mice injected with control tumor cells. These results demonstrate that expression of antisense TGF-β1 by transduced EMT6 cells decreases their tumorigenicity and suggest that this approach of eliminating immune suppression is a potentially useful strategy to enhance antitumor responses.",
keywords = "Antisense TGF-β, Antitumor immunity, EMT6 mammary carcinoma",
author = "Park, {Julie A.} and Ena Wang and Kurt, {Robert A.} and Schluter, {Samuel F.} and Hersh, {Evan M.} and Akporiaye, {Emmanuel T.}",
year = "1997",
language = "English",
volume = "4",
pages = "42--50",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Expression of an antisense transforming growth factor-β1 transgene reduces tumorigenicity of EMT6 mammary tumor cells

AU - Park, Julie A.

AU - Wang, Ena

AU - Kurt, Robert A.

AU - Schluter, Samuel F.

AU - Hersh, Evan M.

AU - Akporiaye, Emmanuel T.

PY - 1997

Y1 - 1997

N2 - Transforming growth factor-β (TGF-β) is a potent immunosuppressive cytokine produced by many tumor cells. Secretion of TGF-β by malignant cells may therefore be a mechanism by which tumor cells escape destruction by tumor-specific T lymphocytes. In order to evaluate the role of tumor-derived TGF-β on tumor progression, we have inhibited the production of this cytokine by introducing a gene encoding antisense TGF-β1 into the EMT6 murine mammary tumor cell line using a retroviral vector (Las-TGF-β1SN). EMT6 cells transduced with this vector (EMT6as-TGF-β1 ) stably expressed the antisense gene and secreted 52% less TGF-β than did tumor cells transduced with the backbone vector alone. Supernatant fluid recovered from tumor cells expressing the antisense TGF-β1 gene also exhibited a decreased capacity to inhibit alloantigen-specific cytotoxic T-cell responses in vitro. Furthermore, tumor growth in mice injected with EMT6as-TGF-β1 tumor cells was inhibited compared to mice injected with control tumor cells. These results demonstrate that expression of antisense TGF-β1 by transduced EMT6 cells decreases their tumorigenicity and suggest that this approach of eliminating immune suppression is a potentially useful strategy to enhance antitumor responses.

AB - Transforming growth factor-β (TGF-β) is a potent immunosuppressive cytokine produced by many tumor cells. Secretion of TGF-β by malignant cells may therefore be a mechanism by which tumor cells escape destruction by tumor-specific T lymphocytes. In order to evaluate the role of tumor-derived TGF-β on tumor progression, we have inhibited the production of this cytokine by introducing a gene encoding antisense TGF-β1 into the EMT6 murine mammary tumor cell line using a retroviral vector (Las-TGF-β1SN). EMT6 cells transduced with this vector (EMT6as-TGF-β1 ) stably expressed the antisense gene and secreted 52% less TGF-β than did tumor cells transduced with the backbone vector alone. Supernatant fluid recovered from tumor cells expressing the antisense TGF-β1 gene also exhibited a decreased capacity to inhibit alloantigen-specific cytotoxic T-cell responses in vitro. Furthermore, tumor growth in mice injected with EMT6as-TGF-β1 tumor cells was inhibited compared to mice injected with control tumor cells. These results demonstrate that expression of antisense TGF-β1 by transduced EMT6 cells decreases their tumorigenicity and suggest that this approach of eliminating immune suppression is a potentially useful strategy to enhance antitumor responses.

KW - Antisense TGF-β

KW - Antitumor immunity

KW - EMT6 mammary carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0030639334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030639334&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 42

EP - 50

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 1

ER -